New Market Study Published: Hairy Cell Leukemia - Pipeline Review, H2 2012
Global Markets Direct's, 'Hairy Cell Leukemia - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Hairy Cell Leukemia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Hairy Cell Leukemia. Hairy Cell Leukemia - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites,...
View full press release